Evidence map›Paper›PMID 35208569›Full record

ArticleMedicina (Kaunas, Lithuania)2022

Serum Uric Acid Levels in Parkinson's Disease: A Cross-Sectional Electronic Medical Record Database Study from a Tertiary Referral Centre in Romania.

Adela Dănău, Laura Dumitrescu, Antonia Lefter, Bogdan Ovidiu Popescu

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Early diagnosis of Parkinson's disease: biomarker study.Frontiers in aging neuroscience · 2025
    Review
  8. Parkinson's Disease: Biomarkers for Diagnosis and Disease Progression.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Relationship between serum uric acid levels and the outcome of STN-DBS in Parkinson's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Adela DănăuDepartment of Clinical Neurosciences, Colentina Clinical Hospital Neurology Division, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Laura DumitrescuDepartment of Clinical Neurosciences, Colentina Clinical Hospital Neurology Division, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.ORCID 0000-0001-5356-1096
Antonia LefterDepartment of Clinical Neurosciences, Colentina Clinical Hospital Neurology Division, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Bogdan Ovidiu PopescuDepartment of Clinical Neurosciences, Colentina Clinical Hospital Neurology Division, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.ORCID 0000-0003-4826-2598
Carol Davila University of Medicine and Pharmacy · RO

Funding

Ministerul Cercetării și Inovării CNFISFDI-2021-0300
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Parkinson DiseaseUric AcidCross-Sectional StudiesElectronic Health RecordsHumansRomaniaTertiary Care CentersUric AcidantioxidantParkinson’s diseaseprophylaxistherapyuric acid

Identifiers

PMID35208569
PMCPMC8877142
OpenAlexW4210338106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.